Albuterol-budesonide fixed-dose combination rescue inhaler for asthma: a plain language summary of the MANDALA study

Ther Adv Respir Dis. 2024 Jan-Dec:18:17534666241232264. doi: 10.1177/17534666241232264.

Abstract

What is this summary about?This summary describes the results of a clinical study called MANDALA that was published in the New England Journal of Medicine in 2022. In the MANDALA study, researchers looked at a new asthma rescue inhaler that contains both albuterol and budesonide in a single inhaler (known as albuterol-budesonide, AIRSUPRA™). This summary describes the results for people aged 18 yearsand older who took part in the study.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Administration, Inhalation
  • Adolescent
  • Adult
  • Aged
  • Albuterol* / administration & dosage
  • Anti-Asthmatic Agents / administration & dosage
  • Asthma* / drug therapy
  • Bronchodilator Agents* / administration & dosage
  • Budesonide* / administration & dosage
  • Drug Combinations*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Nebulizers and Vaporizers*
  • Treatment Outcome
  • Young Adult

Substances

  • Albuterol
  • Drug Combinations
  • Bronchodilator Agents
  • Budesonide
  • Anti-Asthmatic Agents